Pharmacological approach to acute pancreatitis

Keyphrases

• Acute Pancreatitis 100%
• Pharmacological Approaches 100%
• Interleukin-10 50%
• Pharmacological Treatment 50%
• Clinical Trials 50%
• Conflicting Results 50%
• Tumor Necrosis Factor-α 25%
• Nitroglycerin 25%
• Evidence-based 25%
• Anti-inflammatory Drugs 25%
• Randomized Trial 25%
• Meta-analysis 25%
• Randomized Clinical Trial 25%
• Antibiotics 25%
• Non-steroidal Anti-inflammatory Drugs (NSAIDs) 25%
• Diclofenac 25%
• Somatostatin 25%
• Rescue Therapy 25%
• Octreotide 25%
• Pancreas 25%
• Pancreatic Enzymes 25%
• Protease Inhibitors 25%
• Anti-inflammatory Properties 25%
• Nitrogen Oxides 25%
• Experimental Animal Models 25%
• Multi-center Randomized Study 25%
• Indomethacin 25%
• Necrosis 25%
• Sphincter of Oddi 25%
• Quinolones 25%
• Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis 25%
• Pharmacological Prevention 25%
• Gabexate Mesilate 25%
• Infected Necrosis 25%
• Model Trial 25%
• Lactams 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Acute Pancreatitis 100%
• Interleukin 10 50%
• Clinical Trial 50%
• Necrosis 50%
• Cytokine 25%
• Tumor Necrosis Factor 25%
• Glyceryl Trinitrate 25%
• Antiinflammatory Agent 25%
• Randomized Clinical Trial 25%
• Quinolone Derivative 25%
• Diclofenac 25%
• Non-Steroidal Anti-Inflammatory Drug 25%
• Somatostatin 25%
• Proteinase Inhibitor 25%
• Anti-Inflammatory Drug 25%
• Nitrogen Oxide 25%
• Octreotide 25%
• Experimental Animal 25%
• Indometacin 25%
• Pancreatitis 25%
• Beta Lactam Antibiotic 25%
• Pancreas Enzyme 25%
• Gabexate Mesilate 25%